REGN - Spark Newswire

1 minute read

Sanofi – Regeneron’s Immunotherapy Scores European Approval For Skin And Lung Cancer Settings

June 25, 8:51 AM

The European Commission (EC) has approved Sanofi SA (NASDAQ:SNY) and Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) Libtayo (cemiplimab) for two additional indications – basal…

REGN

5 minute read

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs

By Shanthi Rexaline

June 25, 7:32 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24)

ABBV

5 minute read

Regeneron Pharmaceuticals and Sanofi Announced Libtayo Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma

By Charles Gross

June 25, 5:40 AM

Regeneron Pharmaceuticals, Inc.

REGN

1 minute read

Dual-Antibody Cocktail Shows Effectiveness In COVID-19 Animal Models: Reuters

By Vandana Singh

June 22, 7:01 AM

In mice and hamster study, COVID-19 therapies comprising two types of antibodies were found to be effective against…

ABBV

1 minute read

BioNTech Starts Dosing In Mid-Stage Melanoma Vaccine Trial

By Vandana Singh

June 18, 7:08 AM

BioNTech SE (NASDAQ:BNTX) has dosed the first patient in its Phase 2 trial evaluating the BNT111 cancer vaccine. The study evaluates…

BNTX

1 minute read

Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC

By Vandana Singh

June 17, 2:12 PM

Officials on Thursday announced that the Biden Administration plans to invest more than $3.2 billion in developing antiviral medicines to…

BNTX

1 minute read

Media

Cramer Gives His Opinion On Bank of America, Advanced Micro Devices And More

By Craig Jones

June 17, 9:48 AM

On CNBC's "Mad Money Lightning Round," Jim Cramer said Martin Marietta Materials, Inc. (NYSE: MLM) is a well-run company.

AMD

5 minute read

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO

By Shanthi Rexaline

June 16, 8:20 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15)

ACHL

1 minute read

Regeneron Antibody Treatment Cuts Risk Of Death In Some Critical COVID-19 Patients, Large-Scale Study Finds

By Madhukumar Warrier

June 16, 2:00 AM

Regeneron Pharmaceutical Inc.’s (NASDAQ: REGN) COVID-19 monoclonal antibody cocktail reduced the risk of death by 20% in hospitalized COVID-19 patients who have not mounted their own antibody response, a large-scale study in the U.K. published on Wednesday found.

REGN

1 minute read

Clearside Biomedical Shares Soar On Encouraging Safety Profile For Injectable Axitinib In Wet AMD Patients

By Vandana Singh

June 15, 7:27 AM

Clearside Biomedical Inc (NASDAQ:CLSD) has announced positive safety results from Cohort 1 (n=6) of OASIS Phase 1/2a trial of CLS-AX (axitinib…

CLSD

Feed Symbols: REGN